Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
57 participants
INTERVENTIONAL
2011-02-28
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods From 2010/1 to 2015/01, the in-patient persons with difficult to heal diabetic ulcer or Grade 4 pressure ulcer were enrolled. These patients were divided into two groups randomly. The letter of consent was signed by the patient or patient's family. After debridement of the infective wound, the wound of experimental group was packed with a moistened Polyhexamethylene biguamide (PHMB) impregnated gauze (Kerlix AMD, Covidien). A noncollapsible drainage tube (Blake drain, Ethicon) was applied to the wound, and then sealed with 3M Tegaderm Film. The system was connected to a 1-bottle water-seal chest drainage system and to standard wall suction at 125 mmHg negative pressure. The dressing was changed at 72- to 96-hour intervals (twice a week) for a period of 3 weeks. To the control group, the PU foam dressing from KCI was packed and sealed to the wound with the same continuous wall suction at -125mmHg. Investigators observed and recorded the ulcer area twice a week on each time of changing dressing in the following 3 weeks. The percentage of wound area reduction(PWAR) was used as a predictor of wound healing. The repeated measuring data were analyzed using linear mixed mode with SPSS statistical software. This clinical study was approved and monitored by Institutional Review Board of Show Chwan Memorial Hospital.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Negative Pressure Wound Therapy in the Management of Diabetic Foot Ulcers
NCT04093635
Exploring the Effectiveness of Unpowered Negative Pressure Wound Therapy
NCT06911307
Wound Bed Preparation for Diabetic Foot Ulcers
NCT05577104
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
NCT00951080
Evaluation of Negative Pressure Wound Therapy in the Treatment of DFUs Incl. Post Amputation Wounds.
NCT01011387
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
foam
PU foam dressing from KCI
filler dressing of NPWT
a dressing or filler material is used to fit to the contours of a wound (which is covered with a non-adherent dressing film) .
gauze
Polyhexamethylene biguamide (PHMB) impregnated gauze (Kerlix AMD, Covidien)
filler dressing of NPWT
a dressing or filler material is used to fit to the contours of a wound (which is covered with a non-adherent dressing film) .
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
filler dressing of NPWT
a dressing or filler material is used to fit to the contours of a wound (which is covered with a non-adherent dressing film) .
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patient with diabetic ulcer who has severe PAOD untreated
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tainan Municipal Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chao-Chin Yu, Master
Role: STUDY_DIRECTOR
Tainan Municipal Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tainan Municipal Hospital
Tainan City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
990903
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.